• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初级保健中未选择的患者中哮喘和 COPD 的误诊和肺功能检查的使用不足。

Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.

机构信息

Personalized Medicine, Asthma and Allergy, Humanitas Research Hospital, Via Alessandro Manzoni 56, Rozzano, MI, Italy; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, MI, Italy.

Allergy and Respiratory Diseases, University of Catania, AOU Policlinico "Vittorio Emanuele", Via Santa Sofia 78, Catania, Italy.

出版信息

Respir Med. 2018 Sep;142:48-52. doi: 10.1016/j.rmed.2018.07.015. Epub 2018 Jul 24.

DOI:10.1016/j.rmed.2018.07.015
PMID:30170801
Abstract

BACKGROUND

The diagnosis of both asthma and chronic obstructive pulmonary disease (COPD) consists of a combination of classical symptoms and signs, and the evidence of consistent lung function abnormalities. Spiromety has been reported to be underused, possibly for practical difficulties in accessing to a lung function lab. This may lead to misdiagnosis of both asthma and COPD. We aimed to evaluate the frequency of spirometry use and the concordance between doctor-diagnosed asthma and COPD and spirometric patterns, in an unselected cohort of patients sent by general practitioners to perform a spirometry.

METHODS

The first 300 patients consecutively enrolled patients performed spirometry and bronchodilator test with salbutamol 400 mcg. Demographic, clinical and lung function data have been collected.

RESULTS

128 patients (42.7%) declared a doctor-diagnosed asthma and 75 (25%) a doctor-diagnosis of COPD; the remaining subjects never had received any respiratory diagnosis. Only 112 patients with doctor-diagnosed asthma (55.2%) and 114 (56.2%) with doctor-diagnosed COPD have ever performed a spirometry in their entire life (average time since the last spirometry was about 47.0 months). Eighty-nine (69.5%) and 10 (13.3%) patients with respectively doctor-diagnosed asthma and COPD had concordant spirometric patterns with their known diseases.

DISCUSSION

we described a worrying lack of use of spirometry and a high proportion of misdiagnosis, in patients with suspect chronic airway inflammatory diseases and cared by primary care physicians. Novel strategies to overcome this situation include should be implemented to give a better care to our patients.

摘要

背景

哮喘和慢性阻塞性肺疾病(COPD)的诊断包括经典症状和体征的组合,以及一致的肺功能异常的证据。已经报道了肺功能检查的使用不足,可能是因为难以获得肺功能实验室的实际困难。这可能导致哮喘和 COPD 的误诊。我们旨在评估在未经选择的由全科医生转介进行肺功能检查的患者队列中,肺功能检查的使用频率以及医生诊断的哮喘和 COPD 与肺功能模式之间的一致性。

方法

前 300 名连续入组的患者进行了肺功能检查和沙丁胺醇 400 mcg 支气管扩张剂试验。收集了人口统计学、临床和肺功能数据。

结果

128 名患者(42.7%)报告了医生诊断的哮喘,75 名患者(25%)报告了 COPD;其余患者从未接受过任何呼吸系统诊断。只有 112 名有医生诊断的哮喘患者(55.2%)和 114 名有医生诊断的 COPD 患者(56.2%)在其一生中曾进行过肺功能检查(最近一次肺功能检查的平均时间约为 47.0 个月)。分别有 89 名(69.5%)和 10 名(13.3%)有医生诊断的哮喘和 COPD 的患者的肺功能模式与已知疾病相符。

讨论

我们描述了一种令人担忧的情况,即在由初级保健医生照顾的疑似慢性气道炎症性疾病患者中,肺功能检查的使用不足和误诊率较高。应实施新的策略来克服这种情况,以更好地为我们的患者提供护理。

相似文献

1
Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.初级保健中未选择的患者中哮喘和 COPD 的误诊和肺功能检查的使用不足。
Respir Med. 2018 Sep;142:48-52. doi: 10.1016/j.rmed.2018.07.015. Epub 2018 Jul 24.
2
Misdiagnosis of COPD and asthma in primary care patients 40 years of age and over.40岁及以上初级保健患者中慢性阻塞性肺疾病(COPD)和哮喘的误诊情况。
J Asthma. 2006 Jan-Feb;43(1):75-80. doi: 10.1080/02770900500448738.
3
Misdiagnosis Among Frequent Exacerbators of Clinically Diagnosed Asthma and COPD in Absence of Confirmation of Airflow Obstruction.临床诊断的哮喘和慢性阻塞性肺疾病频繁加重患者在未确诊气流受限情况下的误诊
Lung. 2015 Aug;193(4):505-12. doi: 10.1007/s00408-015-9734-6. Epub 2015 Apr 29.
4
Spirometry can be done in family physicians' offices and alters clinical decisions in management of asthma and COPD.肺活量测定可在家庭医生诊所进行,并且会改变哮喘和慢性阻塞性肺疾病管理中的临床决策。
Chest. 2007 Oct;132(4):1162-8. doi: 10.1378/chest.06-2722. Epub 2007 Jun 5.
5
Causes of misdiagnosis of chronic obstructive pulmonary disease: A systematic scoping review.慢性阻塞性肺疾病误诊原因:一项系统的范围综述
Respir Med. 2017 Aug;129:63-84. doi: 10.1016/j.rmed.2017.05.015. Epub 2017 May 29.
6
COPD Underdiagnosis and Misdiagnosis in a High-Risk Primary Care Population in Four Latin American Countries. A Key to Enhance Disease Diagnosis: The PUMA Study.四个拉丁美洲国家高危初级保健人群中慢性阻塞性肺疾病的漏诊和误诊。加强疾病诊断的关键:PUMA研究。
PLoS One. 2016 Apr 13;11(4):e0152266. doi: 10.1371/journal.pone.0152266. eCollection 2016.
7
Predictors of accuracy of diagnosis of chronic obstructive pulmonary disease in general practice.全科医学中慢性阻塞性肺疾病诊断准确性的预测因素。
Med J Aust. 2011 Aug 15;195(4):168-71. doi: 10.5694/j.1326-5377.2011.tb03271.x.
8
Accuracy of diagnosis of COPD and factors associated with misdiagnosis in primary care setting. E-DIAL (Early DIAgnosis of obstructive lung disease) study group.COPD 诊断的准确性及初级保健环境中导致误诊的相关因素。E-DIAL(早期诊断阻塞性肺疾病)研究组。
Respir Med. 2018 Oct;143:61-66. doi: 10.1016/j.rmed.2018.08.006. Epub 2018 Aug 17.
9
Asthma, chronic obstructive pulmonary disease, or both? Diagnostic labeling and spirometry in primary care patients aged 40 years or more.哮喘、慢性阻塞性肺疾病,还是两者都有?40 岁及以上的初级保健患者的诊断标签和肺量测定。
Int J Chron Obstruct Pulmon Dis. 2011;6:597-603. doi: 10.2147/COPD.S25955. Epub 2011 Nov 17.
10
The objective evaluation of obstructive pulmonary diseases with spirometry.通过肺量计对阻塞性肺疾病进行客观评估。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016.

引用本文的文献

1
Reduction in systemic glucocorticoid utilization among COPD patients with type 2 inflammation treated with biologics.使用生物制剂治疗的2型炎症慢性阻塞性肺疾病(COPD)患者全身糖皮质激素使用量的减少。
BMC Pulm Med. 2025 Jul 10;25(1):335. doi: 10.1186/s12890-025-03809-4.
2
A case scenario study on adherence to GINA recommendations by primary care physicians in an area of Southern Italy: the "Progetto Padre 2.0".意大利南部某地区初级保健医生对全球哮喘防治创议(GINA)建议依从性的案例研究:“Progetto Padre 2.0”
BMC Prim Care. 2025 May 3;26(1):144. doi: 10.1186/s12875-025-02846-6.
3
Improving Care for People with Chronic Respiratory Diseases: Taking a Policy Lens.
改善慢性呼吸道疾病患者的护理:以政策视角审视
Adv Ther. 2025 Jun;42(6):2569-2586. doi: 10.1007/s12325-025-03191-x. Epub 2025 Apr 19.
4
Vocal biomarkers correlate with FEV1 variations during methacholine challenge.在乙酰甲胆碱激发试验期间,嗓音生物标志物与第一秒用力呼气容积(FEV1)变化相关。
Clin Transl Allergy. 2025 Apr;15(4):e70055. doi: 10.1002/clt2.70055.
5
Investigating a structured diagnostic approach for chronic breathlessness in primary care: a mixed-methods feasibility cluster randomised controlled trial.探索基层医疗中慢性呼吸困难的结构化诊断方法:一项混合方法可行性整群随机对照试验。
BMJ Open Respir Res. 2025 Feb 13;12(1):e002716. doi: 10.1136/bmjresp-2024-002716.
6
FEV1/FEV6 Cutoff Points to Avoid False Negatives When Using Portable Devices, PICO-6 and COPD-6, in COPD Detection in Primary Healthcare Services.在基层医疗服务中使用便携式设备PICO-6和COPD-6进行慢性阻塞性肺疾病(COPD)检测时,避免假阴性的第一秒用力呼气容积(FEV1)/用力呼气6秒容积(FEV6)截断点
J Clin Med. 2025 Jan 17;14(2):576. doi: 10.3390/jcm14020576.
7
Evaluating the Effectiveness of the COPD Assessment Test (CAT) in Screening for Chronic Obstructive Pulmonary Disease.评估 COPD 评估测试(CAT)在筛查慢性阻塞性肺疾病中的有效性。
Int J Chron Obstruct Pulmon Dis. 2024 Jul 11;19:1623-1633. doi: 10.2147/COPD.S460649. eCollection 2024.
8
Consideration points in the decision making in chronic respiratory diseases.慢性呼吸道疾病决策中的考量要点。
J Rural Med. 2024 Jul;19(3):158-165. doi: 10.2185/jrm.2023-044. Epub 2024 Jul 1.
9
Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software (SPIRO-AID): a protocol for a randomised controlled trial.比较使用或不使用人工智能决策支持软件(SPIRO-AID)对 SPIROmetry 进行解读的初级保健临床医生的表现:一项随机对照试验方案。
BMJ Open. 2024 Jul 1;14(6):e086736. doi: 10.1136/bmjopen-2024-086736.
10
Agreement between self-reported and registered age at asthma diagnosis in Finland.芬兰自我报告和注册哮喘诊断年龄之间的一致性。
BMC Pulm Med. 2024 Mar 15;24(1):133. doi: 10.1186/s12890-024-02949-3.